Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 1/2002

01-02-2002

Sociodemographic predictors of non-attendance at invitational mammography screening – a population-based register study (Sweden)

Authors: Magdalena Lagerlund, Annette E. Maxwell, Roshan Bastani, Erik Thurfjell, Anders Ekbom, Mats Lambe

Published in: Cancer Causes & Control | Issue 1/2002

Login to get access
Metadata
Title
Sociodemographic predictors of non-attendance at invitational mammography screening – a population-based register study (Sweden)
Authors
Magdalena Lagerlund
Annette E. Maxwell
Roshan Bastani
Erik Thurfjell
Anders Ekbom
Mats Lambe
Publication date
01-02-2002
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 1/2002
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1013978421073

Other articles of this Issue 1/2002

Cancer Causes & Control 1/2002 Go to the issue

OriginalPaper

Stage-specific incidence of breast cancer before the beginning of organized screening programs in Italy

OriginalPaper

Childbearing and the risk of leukemia in Sweden

OriginalPaper

The greater impact of menopause on ER– than ER+ breast cancer incidence: a possible explanation (United States)

OriginalPaper

A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands)

Editorial Introduction

Prostate cancer screening practices and cancer control research (United States)

OriginalPaper

The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case–control study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits